Month: January 2022

We are delighted to announce that JelikaLite has been chosen as one of 6 companies to present at the second annual Princeton Women Founders Startup Showcase on January 27, 2022

BioWorld highlights JelikaLite’s breakthrough device designation status from the FDA in their featured article.

JelikaLite has been granted Breakthrough Device Designation from the FDA for our Cognilum System – an individualized, non-invasive, investigational technology for the reduction of symptoms of moderate to severe autism spectrum disorder in pediatric patients.